by Truveta staff | Apr 21, 2025 | Data
Asthma is one of the most studied chronic diseases in medicine, yet decades into the biologics era, researchers face familiar frustrations. Limited phenotyping, unpredictable treatment responses, persistent health disparities, and slow insight cycles can’t meet...
by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
by Truveta staff | Feb 19, 2025 | Data
The need for better cardiovascular device insights Medical device companies are at the forefront of innovation, but a lack of real-world clinical data (RWD) hampers progress in studying cardiovascular device performance. Traditional data sources, such as claims and...
by Truveta staff | Feb 4, 2025 | Data
The start of a new year can be a time for fresh beginnings and new resolutions. Yet for many, it also brings a renewed struggle with anxiety and depression. The cold, dark days of winter, combined with post-holiday stress and lingering financial pressures, can make...
by Truveta staff | Nov 1, 2023 | Data
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
